Comorbidity of psychiatric and substance use disorders in the United States: current issues and findings from the NESARC
about
Diagnostic challenges in alcohol use disorder and alcoholic liver diseasePsychiatric comorbidity and perceived alcohol stigma in a nationally representative sample of individuals with DSM-5 alcohol use disorder.Substance-abusing mothers and fathers' willingness to allow their children to receive mental health treatment.Biological substrates of addiction.The p Factor: One General Psychopathology Factor in the Structure of Psychiatric Disorders?Engagement in assertive community treatment as experienced by recovering clients with severe mental illness and concurrent substance usePersonality disorders and the persistence of substance use disorders: A reanalysis of published NESARC findings.Depressive Symptoms and Associated Clinical Characteristics in Outpatients Seeking Community-Based Treatment for Alcohol and Drug Problems.Factors associated with high use of general practitioner and psychiatrist services among patients attending an addiction rehabilitation center.Age-varying associations between substance use behaviors and depressive symptoms during adolescence and young adulthood.Impact of Exposure to Childhood Maltreatment on Transitions to Alcohol Dependence in Women and Men.Polysubstance use in cannabis users referred for treatment: drug use profiles, psychiatric comorbidity and cannabis-related beliefsAssociations between Polygenic Risk for Psychiatric Disorders and Substance InvolvementConduct disorder and initiation of substance use: a prospective longitudinal study.Cost-effectiveness analysis of Recovery Management Checkups (RMC) for adults with chronic substance use disorders: evidence from a 4-year randomized trialADHD and the externalizing spectrum: direct comparison of categorical, continuous, and hybrid models of liability in a nationally representative sampleCultural Influences on Substance Use Among Hispanic Adolescents and Young Adults: Findings From Project RED.Alcohol stigma and persistence of alcohol and other psychiatric disorders: a modified labeling theory approach.Substance use disorders in adolescent and young adult relatives of probands with bipolar disorder: What drives the increased risk?Safety reports on the off-label use of baclofen for alcohol-dependence: recommendations to improve causality assessment.Integrated Dual Disorder Treatment Implementation in a Large State Sample.Training in Buprenorphine and Office-Based Opioid Treatment: A Survey of Psychiatry Residency Training Programs.Stereotype threat and social function in opioid substitution therapy patients.Transdiagnostic Extension of Delusions: Schizophrenia and Beyond.Medication-assisted treatment for substance use disorders within a national community health center research network.Social, familial and psychological risk factors for mood and anxiety disorders in childhood and early adulthood: a birth cohort study using the Danish Registry System.A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients.The Challenge Behind the Facade: Substance Abuse and Comorbidities.The cross-national structure of mental disorders: results from the World Mental Health Surveys.Effects of the Personalized Recovery Oriented Services (PROS) Program on Hospitalizations.The role of dual diagnosis in health-related quality of life among treatment-seeking patients in Spain.Inhalant Use and Mental Health Problems in Russian Juvenile Delinquents.Individuals developing schizophrenia are hidden among adolescent substance misusers.Need for care and life satisfaction in adult substance use disorder patients with and without attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).Therapeutic Change in a Christian SUD Program: Mental Health, Attachment, and Attachment to God
P2860
Q30435189-D2A0C4B5-5B87-475A-8CC6-B9D1048B192DQ30580766-647EE15A-43ED-47B0-807E-C555AA9F8403Q33819208-1052CE50-60DC-4F31-BB74-C1DD04EC67ADQ33835356-549514CC-97AB-4120-83D1-F2EFA67F613EQ34404372-992940EB-8AF5-4655-918C-557B729CC954Q34484841-63F3CE9C-EF33-408A-9D7D-9F1AD357082EQ34498313-D706253D-5F4F-488B-979D-16A013342BD0Q35037069-4A9129DA-D186-4FAE-8878-A5658557CF88Q36083857-9D52AB60-A7EF-420D-A9BA-DAF8ACDEF068Q36328453-7AFB91CB-7E92-42C0-8EDC-D07DDF51D565Q36904056-F1A59455-B499-4D18-BC21-94A86BA9E949Q37076690-C0817C79-E57C-42E1-A6D8-48ECB433554DQ37172408-F2285E55-B2B9-4BF6-8B1C-8BEAE973FBD6Q37268979-566FD7A2-D8FC-41F5-84E1-97F8669B745AQ37325441-3DE92AE0-BA88-4449-A7D2-F6867DF2A144Q37678716-436B07F5-AADB-4865-B940-04BED80C0590Q37692048-3BB1793C-20DA-461D-AA0C-DFD0E639D20BQ37693443-B26DD6F3-85A7-4DB9-8261-6336A80995BAQ38607036-6B96CA7E-ADBD-48FC-B388-14A5402B80F7Q38778760-E4A89332-617E-4B98-A5E4-68A07308CD58Q38846312-11801603-3426-4570-9CCF-990537468F1BQ39002018-5B6EA2F0-24B0-43B2-BD01-23B0B200A416Q39029911-F8E95095-3821-4D7E-9D21-6C83514753D5Q39234941-A308B4F4-FE31-430F-A71A-F4FADC37531BQ39740604-6314A0B8-A3E9-4848-BF06-D4A3B9D7AB36Q40087826-CDEC2947-29E8-4D8F-9B94-D1D2730BB074Q40582450-8B57C41A-B615-4A23-9144-82E5196687A7Q42316088-FEDAC1E4-29FA-4A46-86E8-F602F8FB4C12Q47287924-963DD20D-05F3-4652-9E38-32DDEB7AE998Q47607854-F21166A3-BD54-4F81-9AEE-E69127EF6E60Q47652202-4EEE83E0-0168-4E78-975B-42EC2DC2DA01Q47709682-57531E76-07C6-4AB3-92E6-A51FE367605EQ50180836-EFA381A5-F916-4034-BB37-1E32EC6D9A9DQ50344789-73ABB43D-E6B3-48A2-B281-6A13F3C1A583Q58256697-3F94183E-21A4-447F-8FC9-F3CD2EF5A4A3
P2860
Comorbidity of psychiatric and substance use disorders in the United States: current issues and findings from the NESARC
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comorbidity of psychiatric and ...... s and findings from the NESARC
@en
Comorbidity of psychiatric and ...... and findings from the NESARC.
@nl
type
label
Comorbidity of psychiatric and ...... s and findings from the NESARC
@en
Comorbidity of psychiatric and ...... and findings from the NESARC.
@nl
prefLabel
Comorbidity of psychiatric and ...... s and findings from the NESARC
@en
Comorbidity of psychiatric and ...... and findings from the NESARC.
@nl
P2860
P1476
Comorbidity of psychiatric and ...... s and findings from the NESARC
@en
P2093
Bari Kilcoyne
P2860
P304
P356
10.1097/YCO.0B013E3283523DCC
P577
2012-05-01T00:00:00Z